Need Help?

Whole genome sequencing of an individual's genomic DNA and that of its lymphoblastoid cell line.

The genetic consequences of cellular transformation by Epstein-Barr-Virus were assessed by comparing whole genome sequences of the original genome (before transformation) and the genome after transformation.

Request Access

legitimate academic institutions need to comply with terms of Data Access Agreement to access EGAS00001000323

THE UCSF Multiple Sclerosis Genetics GroupDATA ACCESS AGREEMENTThis agreement governs the terms on which access will be granted to the sequence data generated by the University of California San Francisco (UCSF) Multiple Sclerosis Genetics Group (MSGG). In signing this agreement, You are agreeing to be bound by the terms and conditions of access set out in this agreement. For the sake of clarity, the terms of access set out in this agreement apply both to the User and the User’s Institution (as defined below). User Institution and User are referred to within the agreement as “You” and “Your” shall be construed accordingly.Definitions: MSGG means the UCSF Multiple Sclerosis Genetics Group, a group of UCSF investigators, a list of which can be found on the website means all and any human genetic data obtained from the MSGG. Data Subject means a person, who has been informed of the purpose for which the Data is held and has given his/her informed consent thereto. User means a researcher whose User Institution has previously completed this Data Access Agreement and has received acknowledgement of its acceptance. Publications means, without limitation, articles published in print journals, electronic journals, reviews, books, posters and other written and verbal presentations of research.User Institution means the organisation at which the User is employed, affiliated or enrolled.Terms and Conditions:In signing this Agreement:1.You agree to use the Data only for the advancement of medical research, according to the consent obtained from sample donors. 2.You agree to preserve, at all times, the confidentiality of information and Data pertaining to Data Subjects. In particular, You undertake not to use, or attempt to use the Data to compromise or otherwise infringe the confidentiality of information on Data Subjects and their right to privacy. 3.You agree not to attempt to link the data provided under this agreement to other information or archive data available for the data sets provided, even if access to that data has been formally granted to you, or it is freely available without restriction, without specific permission being sought from the relevant access committees. 4.You agree not to transfer or disclose the Data, in whole or part, or any identifiable material derived from the Data, to others, except as necessary for data/safety monitoring or program management. Should You wish to share the Data with a collaborator outside from the same Institution, the third party must make a separate application for access to the Data. 5.You agree to use the data for the approved purpose and project described in your application; use of the data for a new purpose or project will require a new application and approval.6.You agree to abide by the terms outlined in the MSGG 'Publications Policy' as set out in Schedule 1.7.You agree to acknowledge in any work based in whole or part on the Data, the published paper from which the Data derives, the version of the data, and the role of the MSGG and the relevant primary collectors and their funders. Suitable wording is provided in the Publications Policy given in Schedule 1.8.You accept that the MSGG, the original data creators, depositors or copyright holders, or the funders of the Data or any part of the Data supplied:a)bear no legal responsibility for the accuracy or comprehensiveness of the Data; andb)accept no liability for indirect, consequential, or incidental, damages or losses arising from use of the Data, or from the unavailability of, or break in access to, the Data for whatever reason.9.You understand and acknowledge that the Data is protected by copyright and other intellectual property rights, and that duplication, except as reasonably required to carry out Your research with the Data, or sale of all or part of the Data on any media is not permitted. 10.You recognise that nothing in this agreement shall operate to transfer to the User Institution any intellectual property rights relating to the Data. The User Institution has the right to develop intellectual property based on comparisons with their own data. 11.You accept that this agreement will terminate immediately upon any breach of this agreement by You and You will be required to destroy any Data held. 12.You accept that it may be necessary for the MSGG or its appointed agent to alter the terms of this agreement from time to time in order to address new concerns. In this event, the MSGG or its appointed agent will contact You to inform You of any changes and You agree that Your continued use of the Data shall be dependent on the parties entering into a new version of the Agreement.13.You agree that you will submit a report to the MSGG Data Access Committee, if requested, on completion of the agreed purpose. The MSGG Data Access Committee agrees to treat the report and all information, data, results, and conclusions contained within such report as confidential information belonging to the User Institution.SCHEDULE 1Publications PolicyThe primary purpose of the UCSF Multiple Sclerosis Genetics Group (MSGG) is to accelerate efforts to identify genome sequence variants influencing major causes of multiple sclerosis, through implementation and analysis of large-scale genome-wide association studies and other genomic technologies. Additional objectives include the development and validation of informatics and analytical solutions appropriate to the scale and nature of the project, as well as use of the data generated to answer important methodological and biological questions relevant to human health in general. The MSGG anticipates that data generated from the project will be used by others, such as required for developing new analytical methods, in understanding patterns of polymorphism and in guiding selection of markers to map genes involved in specific diseases. Authors who use data from the project must acknowledge the UCSF MSGG using the following wording "This study makes use of data generated by the UCSF multiple sclerosis genetics group.Users should note that the MSGG bears no responsibility for the further analysis or interpretation of these data, over and above that published by the MSGG.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS00001000323 Whole Genome Sequencing

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Located in
EGAF00000280120 bam 2.1 GB
EGAF00000280121 bam 2.0 GB
EGAF00000280122 bam 1.5 GB
EGAF00000280123 bam 1.7 GB
EGAF00000280124 bam 1.4 GB
EGAF00000280125 bam 1.4 GB
EGAF00000280126 bam 1.2 GB
EGAF00000280127 bam 1.4 GB
EGAF00000280128 bam 1.2 GB
EGAF00000280129 bam 1.1 GB
EGAF00000280130 bam 1.0 GB
EGAF00000280131 bam 805.6 MB
EGAF00000280132 bam 783.1 MB
EGAF00000280133 bam 794.3 MB
EGAF00000280134 bam 833.8 MB
EGAF00000280135 bam 638.9 MB
EGAF00000280140 bam 1.5 GB
EGAF00000280141 bam 480.3 MB
EGAF00000280142 bam 542.4 MB
EGAF00000280143 bam 493.5 MB
EGAF00000280144 bam 412.2 MB
EGAF00000280145 bam 312.7 MB
EGAF00000280146 bam 83.8 MB
EGAF00000280147 bam 597.4 kB
EGAF00000280148 bam 1.8 GB
EGAF00000280149 bam 1.7 GB
EGAF00000280150 bam 1.3 GB
EGAF00000280151 bam 1.5 GB
EGAF00000280160 bam 1.2 GB
EGAF00000280161 bam 1.2 GB
EGAF00000280162 bam 1.2 GB
EGAF00000280164 bam 651.7 MB
EGAF00000280165 bam 1.0 GB
EGAF00000280166 bam 1.2 GB
EGAF00000280167 bam 1.0 GB
EGAF00000280168 bam 962.7 MB
EGAF00000280169 bam 917.6 MB
EGAF00000280178 bam 661.5 MB
EGAF00000280179 bam 664.6 MB
EGAF00000280180 bam 672.2 MB
EGAF00000280181 bam 708.2 MB
EGAF00000280182 bam 545.2 MB
EGAF00000280183 bam 551.3 MB
EGAF00000280184 bam 413.1 MB
EGAF00000280185 bam 461.9 MB
EGAF00000280186 bam 417.1 MB
EGAF00000280187 bam 345.5 MB
EGAF00000280188 bam 266.7 MB
EGAF00000280189 bam 72.4 MB
EGAF00000280190 bam 318.7 kB
EGAF00000280581 vcf 1.2 GB
EGAF00000280582 vcf 1.3 GB
52 Files (47.9 GB)